Table 3. Cytokine production by TIM-3 positive and negative CD8+ T, CD56dim and CD56bright NK cells.
Non-pregnant | 1st trimester | 2nd trimester | 3rd trimester | ||||||||||
pg/ml | TIM-3+ | TIM-3- | p | TIM-3+ | TIM-3- | p | TIM-3+ | TIM-3- | p | TIM-3+ | TIM-3- | p | |
CD56 | IL-2 | 9,18 | 117,18 | NS | 9,53 | 62,95 | <0,04 | 9,25 | 17,17 | <0,01 | 9,23 | 80,71 | NS |
dim | TNF-α | 1625,01 | 2157,81 | NS | 1820,63 | 2278,48 | NS | 104,75** | 793,57 | NS | 439,75** | 403,62 | NS |
cells | IFN-γ | 2010,29 | 2172,1 | NS | 3095,85 | 3516,78 | NS | 218,03** | 1095,87 | NS | 816,23*** | 696,77$ | NS |
IL-17 | <min | <min | NS | <min | <min | NS | <min | <min | NS | <min | <min | NS | |
CD56 | IL-2 | 20,97 | 114,27 | NS | 13,25 | 39,99 | NS | 14 | 12,78 | NS | 12,93 | 50,89 | NS |
dim | TNF-α | 1211,37 | 1786,06 | NS | 1036,76 | 1315,13 | NS | 641,82 | 461,83 | NS | 1188,97 | 1046,67 | NS |
cells | IFN-γ | 1961,81 | 3513,19 | NS | 2656,23 | 2543,13 | NS | 1632,29 | 979,18 | <0,04 | 1894,9 | 2136,18 | NS |
IL-17 | <min | <min | NS | <min | <min | NS | <min | <min | NS | <min | <min | NS | |
IL-2 | 3076,06 | 6400,32 | <0,05 | 2463,73 | 7812,88 | <0,01 | 687,87 | 1276,9* | NS | 2587,58 | 7471,57 | <0,03 | |
CD8 | TNF-α | 1385,92 | 6064,46 | <0,01 | 1217,89 | 6654,4 | <0,01 | 356,7 | 1468,89$ | NS | 861,61 | 3427,65 | <0,01 |
T cells | IFN-γ | 3455,09 | 5750,34 | NS | 4223,87 | 6306,06 | <0,05 | 908,5$$$ | 2093$$ | NS | 2364,49 | 4851,96 | <0,04 |
IL-17 | 17,33 | 345,2 | <0,04 | 16,93 | 247,9 | <0,05 | 9,83 | 11,49 | NS | 20,83 | 257,01 | <0,04 |
Statistical comparisons were made by using the ANOVA tests. The results were expressed as the mean value. Differences were considered significant when the value of p was equal to or less than 0.05. NS = not statistically significant.
*Sig. from NP;1st; 3rd (p<0,01).
**Sig. from NP;1st (p<0,01).
***Sig. from NP (p<0,05);1st (p<0,01).
$Sig. from 1st (p<0,01).
$$Sig. from 1st (p<0,04).
$$$Sig. from NP (p<0,03);1st (p<0,05).